Pilot Study of the Relationship of Ambient Copeptin to the Aquaretic Effects of Tolvaptan in Patients With Heart Failure.

Trial Profile

Pilot Study of the Relationship of Ambient Copeptin to the Aquaretic Effects of Tolvaptan in Patients With Heart Failure.

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 May 2017

At a glance

  • Drugs Tolvaptan (Primary)
  • Indications Chronic heart failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 May 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 31 Jul 2013 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
    • 31 Jul 2013 Planned end date changed from 1 Jun 2013 to 1 Feb 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top